Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus

被引:38
作者
Flores-Borja, Fabian
Kabouridis, Panagiotis S.
Jury, Elizabeth C.
Isenberg, David A.
Mageed, Rizgar A.
机构
[1] William Harvey Res Inst, Bone & Joint Res Unit, Queen Mary Sch Med & Dent, London EC1M 6BQ, England
[2] UCL, London, England
来源
ARTHRITIS AND RHEUMATISM | 2007年 / 56卷 / 01期
关键词
D O I
10.1002/art.22309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. B lymphocytes from patients with systemic lupus erythematosus (SLE) exhibit defective intracellular signaling, hyperactivity, and autoantibody production. Recent evidence indicates a reduced expression of Lyn kinase, a negative regulator of B cell signaling, and reduced translocation of Lyn into membrane signaling domains in SLE. The present study was undertaken to investigate the causes of this altered regulation of Lyn by assessing the expression levels of regulatory molecules and their translocation into the signaling domains of SLE B lymphocytes. Methods. Blood was obtained from 48 patients with SLE and 28 healthy controls for the assessment of B lymphocytes. Levels and intracellular distribution of Lyn, CD45, COOH-terminal Src kinase (Csk), and c-Cbl were studied by Western blotting, confocal microscopy, and flow cytometry. The kinetics of signaling molecule translocation to the B cell receptor (BCR)-antigen synapse were investigated by confocal microscopy. Results. A profound alteration in the expression and translocation of regulatory signaling molecules in membrane domains of B cells from patients with SLE was observed. B lymphocytes from SLE patients, but not those from healthy controls, expressed a low molecular weight isoform of CD45 in lipid raft signaling microdomains. Kinetic studies revealed that translocation of Lyn, CD45, Csk, and c-Cbl led to increased recruitment and retention of Lyn and CD45 in the BCR-antigen synapse in SLE B cells. Conclusion. The results provide evidence of altered expression and translocation/interaction of kinases and phosphatases in membrane signaling microdomains of B cells from patients with SLE. Altered translocation of CD45 correlated with reduced expression of Lyn, indicating that Lyn is a key molecule in the regulation of BCR-mediated signaling.
引用
收藏
页码:291 / 302
页数:12
相关论文
共 48 条
[31]   CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation [J].
Pan, C ;
Baumgarth, N ;
Parnes, JR .
IMMUNITY, 1999, 11 (04) :495-506
[32]   Signal transduction and glycophosphatidylinositol-linked proteins (LYN, LCK, CD4, CD45, G proteins, and CD55) selectively localize in triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes [J].
Parolini, I ;
Sargiacomo, M ;
Lisanti, MP ;
Peschle, C .
BLOOD, 1996, 87 (09) :3783-3794
[33]   Lipid rafts and B-cell activation [J].
Pierce, SK .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (02) :96-105
[34]   Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII [J].
Pritchard, NR ;
Cutler, AJ ;
Uribe, S ;
Chadban, SJ ;
Morley, BJ ;
Smith, KGC .
CURRENT BIOLOGY, 2000, 10 (04) :227-230
[35]   An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes [J].
Renaudineau, Y ;
Hillion, S ;
Saraux, A ;
Mageed, RA ;
Youinou, P .
BLOOD, 2005, 106 (08) :2781-2789
[36]   Exclusion of CD45 inhibits activity of p56(lck) associated with glycolipid-enriched membrane domains [J].
Rodgers, W ;
Rose, JK .
JOURNAL OF CELL BIOLOGY, 1996, 135 (06) :1515-1523
[37]   Dynamic regulation of Src-family kinases by CD45 in B cells [J].
Shrivastava, P ;
Katagiri, T ;
Ogimoto, M ;
Mizuno, K ;
Yakura, H .
BLOOD, 2004, 103 (04) :1425-1432
[38]   Lipid rafts and signal transduction [J].
Simons, K ;
Toomre, D .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2000, 1 (01) :31-39
[39]   Functional rafts in cell membranes [J].
Simons, K ;
Ikonen, E .
NATURE, 1997, 387 (6633) :569-572
[40]   Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE) [J].
Spronk, PE ;
Horst, G ;
VanderGun, BTF ;
Limburg, PC ;
Kallenberg, CGM .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 (03) :446-453